Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Nature Genetics|September 6, 2000
Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomalyM J Kelley, W Jawien, T L Ortel, et al.
American Journal of Hematology|September 1, 1988
Antifibrinolytic therapy in the management of the Kasabach Merritt syndromeT L Ortel, J J Onorato, C L Bedrosian, et al.
AJNR. American Journal of Neuroradiology|May 12, 1998
Antiphospholipid antibodies: findings at arteriographyJ M Provenzale, D P Barboriak, N B Allen, et al.
The Journal of Rheumatology|September 12, 2001
Risk factors associated with thrombosis in patients with antiphospholipid antibodiesK E Hansen, D F Kong, K D Moore, et al.
AJR. American Journal of Roentgenology|December 1, 1996
Patients with antiphospholipid antibodies: CT and MR findings of the brainJ M Provenzale, D P Barboriak, N B Allen, et al.
European Journal of Radiology|May 20, 1998
Disseminated thrombosis in primary antiphospholipid syndrome: MR findingsJ M Provenzale, C E Spritzer, R C Nelson, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Anticoagulation therapyJ A Ginsberg, M A Crowther, R H White, et al.
Radiology|April 8, 1998
Cerebrovascular disease risk factors: neuroradiologic findings in patients with activated protein C resistanceJ M Provenzale, D P Barboriak, I C Davey, et al.
The Journal of Biological Chemistry|February 25, 1992
Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domainT L Ortel, D Devore-Carter, M Quinn-Allen, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 29, 2001
Antibodies to prothrombin, factor V, and beta2-glycoprotein I and vascular access thrombosisJ J Sands, S A Nudo, K D Moore, et al.
Pageof 7